{"mainPropery":{"diseaseId":9467,"diseaseName":"Alzheimer disease type 2","hasGardWebPage":false,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/9467/alzheimer-disease-type-2","synonyms":["AD2","Alzheimer disease associated with APOE E4","Late onset Alzheimer disease","Late onset familial Alzheimer disease","LOFAD"],"synonyms-with-source":[{"name":"AD2"},{"name":"Alzheimer disease associated with APOE E4"},{"name":"Late onset Alzheimer disease"},{"name":"Late onset familial Alzheimer disease"},{"name":"LOFAD"}],"identifiers":[{"identifierType":"OMIM","identifierId":"104310"},{"identifierType":"ORPHANET","identifierId":"98927"}]},"diseaseCategories":[],"organizations":[{"resourceID":68,"resourceName":"Alzheimer's Association","abbreviation":"","address1":"225 N. Michigan Ave., Fl. 17","address2":"","address3":"","address4":"","address5":"","city":"Chicago","state":"IL","zip":"60601-7633 ","country":"United States","phone":"","tty":"1-866-403-3073 ","tollFree":"1-800-272-3900  (24/7 Helpline)","fax":"1-866-699-1246 ","email":"info@alz.org","url":"https://www.alz.org/","freeText":""},{"resourceID":528,"resourceName":"Alzheimer's Disease Education and Referral Center (ADEAR)","abbreviation":"","address1":"P.O. Box 8250","address2":"","address3":"","address4":"","address5":"","city":"Silver Spring","state":"MD","zip":"20907-8250","country":"United States","phone":"+1-301-495-3311 ","tty":"","tollFree":"1-800-438-4380","fax":"+1-301-495-3334","email":" adear@nia.nih.gov","url":"https://www.nia.nih.gov/health/alzheimers","freeText":""},{"resourceID":530,"resourceName":"Alzheimer's Foundation of America","abbreviation":"","address1":"322 Eighth Avenue","address2":"7th Floor","address3":"","address4":"","address5":"","city":"New York","state":"NY","zip":"10001","country":"United States","phone":"","tty":"","tollFree":"1-866-232-8484 (National Helpline)","fax":"+1-646-638-1546","email":"info@alzfdn.org","url":"https://alzfdn.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/104310' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=omim&cmd=Display&dopt=omim_pubmed_calculated&from_uid=104310' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Alzheimer disease type 2. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Alzheimer+disease+type+2%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Alzheimer disease type 2. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":379,"resourceId":68,"resourceName":"Alzheimer's Association","descriptionText":"The <a href='http://www.alz.org/living_with_alzheimers_just_for_kids_and_teens.asp ' target='_blank'>Alzherimer's Association</a> provides videos and information to help kids and teens deal with the emotions and reactions that are common when a loved one is diagnosed with Alzheimer’s. Click on Alzheimer's Association to view these resources.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Resources for Kids"},{"id":1055,"resourceId":1737,"resourceName":"NIH News - Alzheimer","descriptionText":"NIH News: <a href='http://www.nih.gov/news/health/mar2009/nia-17.htm ' target='_blank'>Scientists Report Important Step in Biomarker Testing for Alzheimer's Disease</a>. National Institute on Aging (NIA). March 17, 2009.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Press Releases"},{"id":1256,"resourceId":1921,"resourceName":"NIH Fact sheet - Alzheimer","descriptionText":"The <a href='http://report.nih.gov/NIHfactsheets/ViewFactSheet.aspx?csid=107&key=A#A' target='_blank'>National Institutes of Health (NIH)</a> has developed a fact sheet on Alzheimer's disease.&nbsp; To view this fact sheet, click on the link above.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1489,"resourceId":68,"resourceName":"Alzheimer's Association","descriptionText":"Learn how Alzheimer's disease affects the brain through the Alzheimer's Association's interactive <a href='http://www.alz.org/brain/01.asp ' target='_blank'>Brain Tour</a>","resourceClassificationName":"Overview","resourceClassificationSectionName":"Diagrams/Images"},{"id":1490,"resourceId":68,"resourceName":"Alzheimer's Association","descriptionText":"Alzheimer's Association <a href='http://www.seniorhousingfinder.org/ ' target='_blank'>Senior Housing Finder<sup>SM</sup></a>, powered by SNAPforSeniors&reg;, is an online senior housing search tool that enables consumers and professionals to:\r\n<ul>\r\n    <li>Access a current list of all licensed care facilities&nbsp; </li>\r\n    <li>View detailed listings for facilities offering services specific to the needs of residents with Alzheimer's or dementia. </li>\r\n    <li>Find facilities that match the needs and preferences identified through the Alzheimer's Association CareFinder&trade;.</li>\r\n</ul>","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":1532,"resourceId":2163,"resourceName":"Social Security Administration","descriptionText":"The <a href='https://secure.ssa.gov/apps10/poms.nsf/lnx/0423022455' target='_blank'>Social Security Administration</a> has included this condition in their Compassionate Allowances Initiative. This initiative speeds up the processing of disability claims for applicants with certain medical conditions that cause severe disability. More information about <a href=\"http://www.ssa.gov/compassionateallowances/index.htm\" target=\"_blank\">Compassionate Allowances</a> and <a href=\"https://www.ssa.gov/benefits/disability/\" target=\"_blank\">applying for Social Security disability</a> is available online.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=98927' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:104310' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2340,"resourceId":3583,"resourceName":"Job Accommodation Network","descriptionText":"The <a href='https://askjan.org/disabilities/Alzheimer-s-Disease.cfm' target='_blank'>Job Accommodation Network</a> (JAN) has information on workplace accommodations and disability employment issues related to this condition. JAN is a service of the Office of Disability Employment Policy in the U.S. Department of Labor.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Community Resources"},{"id":2722,"resourceId":4053,"resourceName":"Patient Registry","descriptionText":"A registry supports research by collecting of information about patients that share something in common, such as being diagnosed with Alzheimer disease type 2. The type of data collected can vary from registry to registry and is based on the goals and purpose of that registry. Some registries collect contact information while others collect more detailed medical information. <a href=\"https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries\" target=\"_blank\">Learn more about registries</a>.<br />\r\n<br />\r\nRegistries for&nbsp;Alzheimer disease type 2:<br />\r\n<a href='https://www.endalznow.org/about-the-registry/how-the-registry-works' target='_blank'>Alzheimer's Prevention Registry</a><br />&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"}],"overviewQuestion":{"questionId":0,"dateModified":"0001-01-01T00:00:00"},"basicQuestions":[],"references":[],"relatedDiseases":[{"relatedDiseaseId":12799,"relatedDiseaseName":"Late-Onset Familial Alzheimer Disease","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[{"caseId":16634,"abbreviatedInquiry":"I once heard that Alzheimers Disease skips generations.&nbsp; For example, my mother's father suffered from this illness. Does my mother have a higher chance of developing the condition than my brother and I?","caseQuestions":[{"questionId":172,"questionText":"What is Alzheimer disease?","answerText":"<strong>Alzheimer disease (AD) </strong>is a degenerative disease of the brain that causes gradual loss of memory, judgment, and the ability to function socially. Alzheimer disease currently affects about 5 million people.[125] About 75 percent of Alzheimer disease cases are classified as <a href=\"http://www.ncbi.nlm.nih.gov/books/NBK5191/def-item/sporadic/\" target=\"_blank\">sporadic</a>, which means they occur in people with no history of the disorder in their family. Although the cause of these cases is unknown, genetic changes are likely to play a role. Virtually all sporadic cases of Alzheimer disease begin after age 65, and the risk of developing this condition increases as a person gets older.[126]<br />\r\n<br />\r\nAD can be subdivided into two groups based on the age of onset:[127]<br />\r\n(1) Early-onset (1%-6% of the cases) which start in people younger than  60- 65 years of age<br />\r\n(2) Late-onset, which starts in people older than 65 years old.<br />\r\n<br />\r\nIn about 25% of cases, AD is familial (2 or more people in a family have AD). For more information, please visit GARD's <a href=\"https://rarediseases.info.nih.gov/gard/632/alzheimer-disease-familial/resources/1\" target=\"_blank\">familial Alzheimer disease</a> Web page.","dateModified":"2015-11-02T00:00:00","references":[{"referenceId":125,"authors":"","articleTitle":"Alzheimer Disease","bookWebsiteJournalTitle":"Genetics Home Reference","date":"May, 2013","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition=alzheimerdisease","dateAccessed":"2015-09-30T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":126,"authors":"","articleTitle":"Alzheimer's Facts and Figures","bookWebsiteJournalTitle":"Alzheimer's association","date":"2015","volume":"","pages":"","url":"http://www.alz.org/alzheimers_disease_facts_figures.asp","dateAccessed":"2015-09-30T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":127,"authors":"","articleTitle":"Alzheimer Disease Overview","bookWebsiteJournalTitle":"GeneReviews","date":"September 24, 2015","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1161/","dateAccessed":"2015-09-30T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":171,"questionText":"Can you tell me my chances of developing Alzheimers disease?","answerText":"No, only your personal health care provider can address your and your family's specific risks. However we have provided general information about the inheritance of Alzheimer disease in the questions and answers below. To learn about the risks specific to you and your family, we recommend that you speak with a genetics professional. A genetics professional can carefully review your family history to answer your specific questions. More information on how to find a genetics professional is available from the Genetics Home Reference at <a href=\"http://ghr.nlm.nih.gov/handbook/consult\">http://ghr.nlm.nih.gov/handbook/consult</a>.","dateModified":"2013-07-05T15:57:00","references":[]},{"questionId":173,"questionText":"Can Alzheimer disease be passed through families?","answerText":"About 75 percent of Alzheimer disease (AD) cases are classified as <a href=\"http://www.ncbi.nlm.nih.gov/books/NBK5191/def-item/sporadic/\" target=\"_blank\">sporadic</a>, which means that no other blood relatives are affected. The cause of these cases is not known at this time, but genetics may play a part. The risk of developing the condition increases as a person gets older.<br />\r\n<br />\r\nThe remaining 25 percent of Alzheimer disease cases are hereditary, which means they are caused by changes (<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutated</a>) genes and tend to cluster in families. These cases can be divided into early-onset familial disease (diagnosed before age 65) and late-onset familial disease.[125] <br />\r\n<br />\r\nEarly-onset familial AD (AD subtypes 1, 3 and 4 caused by mutations in the <em><a href=\"http://http://ghr.nlm.nih.gov/gene/APP\" target=\"_blank\">APP</a></em> gene, <em><a href=\"http://ghr.nlm.nih.gov/gene/PSEN1\" target=\"_blank\">PSEN1</a></em> gene, and <em><a href=\"http://ghr.nlm.nih.gov/gene/PSEN2\" target=\"_blank\">PSEN2</a></em> gene respectively) is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> manner and accounts for&nbsp;about 5% of the total cases of familial AD. The late-onset familial AD (AD subtype 4) is related to mutations in the <em><a href=\"http://ghr.nlm.nih.gov/gene/APOE\" target=\"_blank\">APOE</a> </em>gene (e4 allele) and&nbsp;results in an increased <a href=\"http://ghr.nlm.nih.gov/handbook/mutationsanddisorders/predisposition\" target=\"_blank\">susceptibility</a>  of having the disease.[127]","dateModified":"2015-09-30T00:00:00","references":[{"referenceId":125,"authors":"","articleTitle":"Alzheimer Disease","bookWebsiteJournalTitle":"Genetics Home Reference","date":"May, 2013","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition=alzheimerdisease","dateAccessed":"2015-09-30T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":127,"authors":"","articleTitle":"Alzheimer Disease Overview","bookWebsiteJournalTitle":"GeneReviews","date":"September 24, 2015","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1161/","dateAccessed":"2015-09-30T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2567,"questionText":"How can I find a genetics professional in my area?","answerText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by  the <a href=\"https://www.acmg.net/ACMG/Find_Genetic_Services/ACMG/ISGweb/FindaGeneticService.aspx?hkey=720856ab-a827-42fb-a788-b618b15079f9\" target=\"_blank\">American College of Medical Genetics</a>&nbsp;and the&nbsp;<a href=\"https://www.findageneticcounselor.com/\" target=\"_blank\">National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also <a href=\"http://ghr.nlm.nih.gov/handbook/consult?show=all\" target=\"_blank\">learn more about genetic consultations</a> from Genetics Home Reference.","dateModified":"2017-12-06T00:00:00","references":[]}]}],"news":[{"newsId":667,"dateCreated":"2019-10-02T11:16:00","publishDate":"2019-10-02T00:00:00","title":"New NIH-funded Research Centers Speed and Diversify Alzheimer’s Drug Discovery","description":"To help meet the urgent need for therapies that will effectively treat or prevent Alzheimer&rsquo;s disease, the National Institute on Aging (NIA) has launched two new research centers with funding expected to total more than $73 million over the next five years. The Alzheimer Centers for the Discovery of New Medicines are designed to diversify and reinvigorate the Alzheimer&rsquo;s disease drug development pipeline. NIA is part of the National Institutes of Health.","url":"https://www.nih.gov/news-events/news-releases/new-nih-funded-translational-research-centers-speed-diversify-alzheimers-drug-discovery","lastModified":"2020-05-22T11:53:00","isFeatured":false},{"newsId":665,"dateCreated":"2019-08-27T11:17:00","publishDate":"2019-08-27T00:00:00","title":"Tissue Model Reveals Role of Blood-Brain Barrier in Alzheimer’s","description":"The blood-brain barrier is the normally tight border that prevents harmful molecules in the bloodstream from entering the brain.  A recent study found that the blood-brain barrier can be damaged by the protein aggregates that form in the brains of Alzheimer&rsquo;s patients. This allows toxins to enter the brain, further harming neurons. Researchers at MIT have found a drug, etodolac, that restores the blood-brain barrier and continue to search for effective drugs.","url":"http://news.mit.edu/2019/alzheimers-model-blood-brain-0812","lastModified":"2019-08-27T11:17:00","isFeatured":false},{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":14303,"phenoTypeName":"Alzheimer disease","percentRanges":"-"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":6020,"phenoTypeName":"Dementia","percentRanges":"-"},{"phenoTypeId":6255,"phenoTypeName":"Late onset","percentRanges":"-"},{"phenoTypeId":5191,"phenoTypeName":"Long-tract signs","percentRanges":"-"},{"phenoTypeId":9388,"phenoTypeName":"Parkinsonism","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Alzheimer_disease_type_2"}